Immunovant Inc. Common Stock vs iShares US Power Infrastructure ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while iShares US Power Infrastructure ETF trades at $25.44 (market cap $446.54M). The key difference: Immunovant Inc. Common Stock is far larger — about 14× iShares US Power Infrastructure ETF's market cap, and iShares US Power Infrastructure ETF is more actively traded (160,852 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and iShares US Power Infrastructure ETF for 14 Days on average.
| IMVT | POWR | |
|---|---|---|
Market Cap | $6.25B | $446.54M |
Volume | 1,755,411 | 160,852 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $28.22 |
52-Week Low | $17.03 | $23.20 |
Typical Hold Time | 1 Days | 14 Days |
Enterprise Value | $5.35B | — |
Trailing returns across standard periods
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →iShares U.S. Power Infrastructure ETF seeks exposure to U.S. companies involved in power infrastructure. Its holdings may include electric utilities, transmission and distribution businesses, and electrical equipment providers.
Read more on POWR →